Cargando…

Paraneoplastic Cerebellar Ataxia Can Affect Prognosis in High-Grade Serous Ovarian Cancer: A Case Report

The reported case is a 61-year-old woman, admitted for gradual onset of gait disturbances and dysphonia. The serum immunological panel revealed anti-Yo autoantibodies, suggestive of a paraneoplastic syndrome (PNS). A PET-CT revealed a suspicious left ovarian mass with retroperitoneal nodal involveme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liapi, Aikaterini, Sarivalasis, Apostolos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506384/ https://www.ncbi.nlm.nih.gov/pubmed/32999664 http://dx.doi.org/10.1159/000509029

Ejemplares similares

Dual first-line maintenance by PARP inhibitor and bevacizumab can cause confusion in high-grade serous ovarian cancer: A case of PRES and a review of the literature
por: Liapi, Aikaterini, et al.
Publicado: (2023)

Lymph Node Involvement in Recurrent Serous Borderline Ovarian Tumors: Current Evidence, Controversies, and a Review of the Literature
por: Wetterwald, Laureline, et al.
Publicado: (2023)

Paraneoplastic cerebellar ataxia with central hypoventilation
por: Kunchok, Amy, et al.
Publicado: (2016)

So-Called Serous Carcinoma of the Uterine Cervix with BRCA2 Mutation: Case Report and Review of the Literature
por: Herrera Gómez, Ruth Gabriela, et al.
Publicado: (2021)

Septin-3 autoimmunity in patients with paraneoplastic cerebellar ataxia
por: Miske, Ramona, et al.
Publicado: (2023)

Paraneoplastic opsoclonus-myoclonus syndrome as a presentation of high grade serous ovarian cancer
por: Stewart, Kimberly T., et al.
Publicado: (2019)

Paraneoplastic cerebellar ataxia in Merkel cell carcinoma of unknown primary
por: Queen, Dawn, et al.
Publicado: (2019)

Paraneoplastic cerebellar ataxia and antibodies to metabotropic glutamate receptor 2
por: Ruiz-García, Raquel, et al.
Publicado: (2019)

VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature
por: Liapi, Aikaterini, et al.
Publicado: (2021)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia
por: Becker, Esther B E, et al.
Publicado: (2012)

Paraneoplastic cerebellar degeneration associated with ovarian cancer
por: RUSSO, ALESSIA ERIKA, et al.
Publicado: (2013)

Spinal anaesthesia for a caesarean section in a patient with paraneoplastic cerebellar ataxia
por: Tuna, Ayca Tas, et al.
Publicado: (2017)

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2020)

AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization
por: Azzalini, Eros, et al.
Publicado: (2022)

Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness
por: Wang, Zhihang, et al.
Publicado: (2022)

Ovarian cancer revealed by paraneoplastic cerebellar degeneration: a case report
por: Elomrani, Fadwa, et al.
Publicado: (2014)

Update in Autoimmune Movement Disorders: Newly Described Antigen Targets in Autoimmune and Paraneoplastic Cerebellar Ataxia
por: Garza, Madeline, et al.
Publicado: (2021)

Fallopian tube secreted protein affects ovarian metabolites in high grade serous ovarian cancer
por: Bergsten, Tova M., et al.
Publicado: (2022)

Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013)

Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism: Case report
por: Abdulaziz, Ammar Taha Abdullah, et al.
Publicado: (2018)

Treatment of Paraneoplastic Cerebellar Degeneration
por: Greenlee, John E.
Publicado: (2013)

Update on Paraneoplastic Cerebellar Degeneration
por: Loehrer, Philipp Alexander, et al.
Publicado: (2021)

Repetitive transcranial magnetic stimulation (rTMS) as a therapeutic option in paraneoplastic cerebellar ataxia – a case report
por: Jemna, Nicoleta, et al.
Publicado: (2022)

Paraneoplastic myositis secondary to poorly differentiated serous carcinoma of ovarian/tubal origin
por: Raizman, Zachary, et al.
Publicado: (2017)

High-grade B-cell lymphoma with gastroduodenal involvement showing paraneoplastic cerebellar degeneration: a case report
por: Wang, Chunsaier, et al.
Publicado: (2022)

VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
por: Zong, Liju, et al.
Publicado: (2019)

Neoantigens and the tumor microenvironment play important roles in the prognosis of high-grade serous ovarian cancer
por: Yang, Hua, et al.
Publicado: (2022)

Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer
por: Ihlow, Jana, et al.
Publicado: (2022)

Tumor and local lymphoid tissue interaction determines prognosis in high-grade serous ovarian cancer
por: Lu, Haonan, et al.
Publicado: (2023)

High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer
por: Sopo, Minna, et al.
Publicado: (2020)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

High-grade serous ovarian cancer: the clone wars
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2017)

Molecular Management of High-Grade Serous Ovarian Carcinoma
por: Punzón-Jiménez, Paula, et al.
Publicado: (2022)

Paraneoplastic Cerebellar Degeneration Associated With Ovarian Adenocarcinoma: A Case Report and Review of Literature
por: Renjen, Pushpendra Nath, et al.
Publicado: (2018)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Paraneoplastic cerebellar degeneration in Hodgkin's lymphoma
por: Suri, Vinit, et al.
Publicado: (2012)

Lipid Droplet Accumulation Independently Predicts Poor Clinical Prognosis in High-Grade Serous Ovarian Carcinoma
por: Iwahashi, Naoyuki, et al.
Publicado: (2021)

Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
por: Feng, Li-yuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_npv5n57ka122sajn9qfbs3r1u7